Cronos Group Inc (CRON)
$14.91 0.06 (0.40%)
7:05 EDT CRON Stock Quote Delayed 15 Minutes
Previous Close $14.97
Market Cap 2.63B
PE Ratio -
Volume (Avg. Vol.) 708
Day's Range 14.86 - 15.33
52-Week Range 5.61 - 25.10
Dividend & Yield N/A (N/A)
CRON Stock Predictions, Articles, and Cronos Group Inc News
- From InvestorPlace
- From the Web
Although CRON stock appears to be trading at a deep discount, prospective buyers should take into consideration the coming confluence of technical and fundamental headwinds.
Although CRON stock has held up better than some of its peers, sector volatility appears ready to take it down too.
Aurora Cannabis stock broke down from a bearish technical setup last week. Can ACB repair the damage or are shares heading lower?
The bloom is gone for the marijuana sector. Even the more conservative CRON stock is now feeling the side effects.
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.
Cronos is taking its time, which isn't a bad thing long-term. But it could be a near-term issue for CRON stock.
Cronos currently has a market cap of $5.4 billion. In the first quarter, it closed the Altria investment. At the end of March, it had $1.8 billion in cash on the balance sheet. CRON stock is trading at less than 3x cash.
By Thomas Niel
Canopy Growth (CGC) is poised to dominate the American cannabis market. But after a weak earnings report, its current sky-high valuation is in question.
Cronos Group should benefit from the Altria investment and the growth of the cannabis industry, but CRON stock will struggle to benefit.
Options trading was buzzing in Canopy Growth, Microsoft and Netflix. Here are the metrics that matter moving forward.
CGC stock will report earnings on June 20th, just a day after it got the OK from shareholders for its $3.4 billion deal for Acreage Holdings.
Although each of these are promising stocks to buy, some bullish theses are harder to visualize than others. But each has significant long-term potential that can't be ignored.
The U.S.-China trade war makes a strong case for buying marijuana penny stocks as full legalization provides an easy catalyst for economic activity and growth.
Cronos may have $2 billion in cash but it is strategic in the way it spends that. So far the right moves are helping Cronos stock.
Thursday’s 2.29% slide in CGC stock price reflects uncertainty about Canopy Growth’s forthcoming Q4 2019 results, cannabis market volatility.
CRON stock has a solid band of support so the bulls can mount a 20% rally from here. The bears are at a disadvantage.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!